Find a Therapeutic By Name

Search By Attributes

Therapy Type

Combination
DNA/RNA-based
Immunotherapy (active)
Immunotherapy (passive)
Other
Procedural Intervention
Small Molecule
Supplement, Dietary

Condition

Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Cerebral Amyloid Angiopathy
Frontotemporal Dementia
Mild Cognitive Impairment
Parkinson's Disease

Keyword

2 Therapeutics

Search Results

Name	Synonyms	FDA Status	Company	Target Type	Therapy Type	Approved For
AXS-05	Dextromethorphan/bupropion	Alzheimer's Disease (Phase 2/3)	Axsome Therapeutics, Inc.	Other Neurotransmitters	Combination, Small Molecule
Troriluzole	BHV-4157, trigriluzole, FC-4157	Alzheimer's Disease (Phase 2/3)	Biohaven Pharmaceuticals	Other Neurotransmitters	Other